Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab and Vinorelbine in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
China CellSearch Study
- Status
- COMPLETED
- Phase
- N/A
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Triple Negative Breast Cancer Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Demonstrate Efficacy and Safety of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Safety, Efficacy and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ixabepilone + Carboplatin Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca
- Status
- COMPLETED
- Phase
- EARLY_PHASE1